Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial

Home, PD; Lam, RLH; Carofano, WL; Golm, GT; Eldor, R; Crutchlow, MF; Marcos, MC; Rosenstock, J; Hollander, PA; Gallwitz, B

Home, PD (reprint author), ICM Diabet, Med Sch, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.

DIABETES OBESITY & METABOLISM, 2018; 20 (9): 2220

Abstract

Aim: To compare the efficacy and safety of MK-1293 insulin glargine (Mk-Gla; 100 U/mL) with originator insulin glargine, Lantus (Sa-Gla), in people wi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索